Author's posts
HHS is distributing the experimental antiviral remdesivir to hospitals hardest hit by COVID-19
Gilead Sciences committed to supplying approximately 607,000 vials over the next six weeks to treat an estimated 78,000 hospitalized patients.
CMS promotes value-based insurance design in final payment notice for 2021
Insurers get a one week extension to finalize 2021 exchange plan applications, giving them time to analyze the effect of COVID-19 in setting premiums.
AHIP and HFMA offer billing guidance for COVID-19 inpatient care at alternate sites
AHIP and HFMA expect to issue voluntary billing guidance for outpatient services soon.
CVS digital strategies due to COVID-19 helped drive strong first quarter
Consumer-centric digital services could become the new norm, according to CEO and President Larry Merlo.
Predictive analytics needs a bedside, rather than scientific, manner
A continuous cardiorespiratory monitor uses a much larger data set for an analysis of risk for a subacute, potentially catastrophic, illness.
Insurers’ credit profiles can withstand coronavirus costs, Moody’s says
U.S. health insurers will remain profitable under the most likely scenarios, despite the highly uncertain severity and duration from COVID-19.
Humana is waiving costs for all primary care and behavioral health visits for MA members
Cost sharing is being waived for in-network primary care, behavioral health and telehealth visits.
Kaufman Hall acquires Change’s Connected Analytics business
HHS begins distributing targeted funding to hot spots and rural hospitals
$12 billion is going to 395 hospitals that provided inpatient care for 100 or more COVID-19 patients.
More money is needed for hospitals to care for COVID-19 patients, AHA and ANA tell Congress
New funds should not be used to cover the cost of treating the uninsured, though Congress needs to address that, providers say.
